Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

BACKGROUND: Detection of minimal residual disease (MRD) in the early phase of therapy is the most powerful predictor of relapse risk in children with acute lymphoblastic leukaemia (ALL). AIM: We aimed to determine the significance of MRD at the end of remission induction therapy in the prediction of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Access Maced J Med Sci
Auteurs principaux: Jovanovska, Aleksandra, Martinova, Kata, Kocheva, Svetlana, Trajkova-Antevska, Zorica, Coneska-Jovanova, Biljana, Panovska-Stavridis, Irina, Stankovikj, Svetlana, Trajkova, Sanja, Dimovski, Aleksandar
Format: Artigo
Langue:Inglês
Publié: Republic of Macedonia 2019
Sujets:
Clinical Science
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6901875/
https://ncbi.nlm.nih.gov/pubmed/31844443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2019.752
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires